Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 24
Issue Date | Title | Author(s) |
2022 | An adaptable in vitro cytokine release assay (CRA): Susceptibility to cytokine storm in COVID-19 as a model | Alam, Masih; Choudhury, Rawshan; Lamers, Robert-Jan |
2022 | Mucosal delivery of RNA vaccines by Newcastle disease virus vectors | García-Sastre, Adolfo |
2022 | Chemotherapy induces plasmatic antioxidant changes in pediatric patients with acute lymphoid leukemia B that correlate to disease prognosis | Ricardo Garbim, Matheus; Ellen Broto, Geise; Celso Trigo, Fausto |
2022 | New insights into the tumour immune microenvironment of nasopharyngeal carcinoma | Forder, Aisling; L. Stewart, Greg; Telkar, Nikita; L. Lam, Wan; Garnis, Cathie |
2022 | T cell immunity is key to the pandemic endgame: How to measure and monitor it | Schwarz, Megan; Mzoughi, Slim; Lozano-Ojalvo, Daniel |
2022 | NMR spectroscopy spotlighting immunogenicity induced by COVID-19 vaccination to mitigate future health concerns | Ali, Sher; Nedvˇedov´a, ˇStˇep´anka; Badshah, Gul |
2022 | Mechanobiology of immune cells: Messengers, receivers and followers in leishmaniasis aiding synthetic devices | Khandibharad, Shweta; Nimsarkar, Prajakta; Singh, Shailza |
2022 | Dach1 transcription factor regulates the expression of peripheral node addressin and lymphocyte trafficking in lymph nodes | Shintani, Arisa; Fukai, Shoko; Nobusawa, Reika |
2022 | Rapid peptide exchange on MHC class I by small molecules elucidates dynamics of bound peptide | Hadeler, Andries; Saikia, Ankur; Zacharias, Martin; Springer, Sebastian |
2022 | Salmonella-induced immune response reduces recurrence and tumor dissemination in preclinical melanoma model | M´onaco, Amy; C. Plata, María; Chilibroste, Sofía |
2022 | Nature of viruses and pandemics: Coronaviruses | Enjuanes, Luis |
2022 | From Alpha to omicron: The response of T cells | Grifoni, Alba; Sette, Alessandro |
2022 | The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites | A. Lampros, Elizabeth; G. Kremer, Paul; S. Aguilar Díaz de Le´on, Jesús |
2022 | Clinically approved combination immunotherapy: Current status, limitations, and future perspective | Lu, Ligong; Zhan, Meixiao; Li, Xian-Yang |
2022 | Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection | Arish, Mohd; Naz, Farha |
2022 | DDX3X structural analysis: Implications in the pharmacology and innate immunity | De Colibus, Luigi; Stunnenberg, Melissa; B.H. Geijtenbeek, Teunis |
2022 | Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface | M. Ruggiero, Fernando; Springer, Sebastian |
2022 | TLR ligand ligation switches adenosine receptor usage of BMDCs leading to augmented Th17 responses in experimental autoimmune uveitis | Sun, Deming; Shao, Hui; J. Kaplan, Henry |
2022 | All trans retinoic acid as a host-directed immunotherapy for tuberculosis | Z. Bahlool, Ahmad; Grant, Conor; Ann Cryan, Sally- |
2022 | The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions | Lombardi, Carlo; Berti, Alvise; Cottini, Marcello |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 24